Crossmark

Duodenal-Jejunal Bypass Liner (DJBL) Improves Cardiovascular Risk Biomarkers and Predicted 4-Year Risk of Major CV Events in Patients with Type 2 Diabetes and Metabolic Syndrome

Crossref DOI link: https://doi.org/10.1007/s11695-019-04324-2

Published Online: 2020-01-02

Published Print: 2020-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Roehlen, Natascha https://orcid.org/0000-0002-6653-8765
Laubner, Katharina

Bettinger, Dominik

Schwacha, Henning

Hilger, Hanna

Koenig, Carolin

Grueninger, Dirk

Krebs, Andreas

Seufert, Jochen
Funding

Funding for this research was provided by:

Deutsche Diabetesgesellschaft (Allgemeine Projektförderung)
License Information

Text and Data Mining valid from 2020-01-02

Version of Record valid from 2020-01-02
More Information

Article History

First Online: 2 January 2020

Compliance with Ethical Standards

:

: J. S. and K. L have attended advisory boards and speaker’s bureaus for GI-Dynamics, Lexington, Massachusetts, USA. The other authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below